Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000-2011

被引：90

作者：

Hong, Ki Bae ^{[1
]}

Choi, Eun Hwa ^{[1
,2
]}

Lee, Hoan Jong ^{[1
,2
]}

Lee, Seong Yeon ^{[1
]}

Cho, Eun Young ^{[1
]}

Choi, Jae Hong ^{[1
]}

Kang, Hyun Mi ^{[1
]}

Lee, Jina ^{[3
]}

Ahn, Young Min ^{[4
]}

Kang, Yeon-Ho ^{[5
]}

Lee, Joon-Ho ^{[6
]}

机构：

[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea

[2] Seoul Natl Univ, Coll Med, Seoul 110769, South Korea

[3] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea

[4] Seoul Eulji Hosp, Seoul, South Korea

[5] Korea Ctr Dis Control & Prevent, Seoul, South Korea

[6] Kangwon Natl Univ Hosp, Chunchon, South Korea

来源：

EMERGING INFECTIOUS DISEASES | 2013年 / 19卷 / 08期

基金：

新加坡国家研究基金会;

关键词：

REAL-TIME PCR; MOLECULAR ANALYSIS; STRAINS; EPIDEMIOLOGY;

D O I：

10.3201/eid1908.121455

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In Korea, Mycoplasma pneumoniae was detected in 255/2,089 respiratory specimens collected during 2000-2011; 80 isolates carried 23S rRNA gene mutations, and 69/123 culture-positive samples with the mutation were resistant to 5 macrolides. During 2000-2011, prevalence of the mutation increased substantially. These findings have critical implications for the treatment of children with mycoplasma pneumonia.

引用

页码：1281 / 1284

页数：4

共 16 条

[1]

[Anonymous], 2011, Performance standards for antimicrobial disk susceptibility tests

[2]

approved standard M2-A11, V11th

[3] Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections [J].